Aviva
AMED

Aviva’s Amedisys AMED Stock Holding History

Aviva’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,956
Closed -$1.78M – 1001
2022
Q2 		$1.78M Buy
16,956
+2,137
+14% +$273K 0.01% 896
2022
Q1 		$2.55M Sell
14,819
-787
-5% -$118K 0.01% 738
2021
Q4 		$2.53M Buy
15,606
+6,234
+67% +$1M 0.01% 795
2021
Q3 		$1.4M Buy
+9,372
New +$1.95M 0.01% 908
2021
Q2 		– Sell
-4,346
Closed -$1.15M – 867
2021
Q1 		$1.15M Sell
4,346
-1,045
-19% -$295K 0.01% 889
2020
Q4 		$1.58M Sell
5,391
-4,367
-45% -$1.12M 0.01% 748
2020
Q3 		$2.31M Sell
9,758
-1,807
-16% -$411K 0.01% 683
2020
Q2 		$2.3M Sell
11,565
-9,061
-44% -$1.69M 0.01% 696
2020
Q1 		$3.79M Buy
20,626
+8,404
+69% +$1.5M 0.03% 498
2019
Q4 		$2.04M Buy
+12,222
New +$1.82M 0.01% 692

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aviva's AMED Position: Q3 2022 in Review

Aviva sold out of Amedisys (AMED) in Q3 2022, closing a stake of 16,956 shares — an estimated $1.78M sold.

Aviva first reported a position in AMED in Q4 2019 and held it in 10 quarters. The position peaked at $3.79M in Q1 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Aviva reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 16,956 Amedisys shares in Q3 2022, an estimated $1.78M.
  • Aviva first reported a position in Amedisys in Q4 2019 and held it in 10 quarters.
  • Aviva's Amedisys position peaked at $3.79M in Q1 2020.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.